Rohona Mascharak
Psychiatric/Mental Health · Pensacola, FLNPI 1003267386
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $33,550 of the $42,051 with a category attached, or 79.8%. AbbVie accounts for 94.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $41,615 and has fallen 99.7% since, to $108 in 2025. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 185 payments — averaging $227.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$40K
- Otsuka America Pharmaceutical, Inc.$481
- Alkermes, Inc.$321
- Neos Therapeutics, LP$219
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$219
- Takeda Pharmaceuticals U.S.A., Inc.$149
- plus $760 from 13 others
What the payments were for
- Speaking & faculty fees$33,55080%
- Travel & lodging$5,41113%
- Food & beverage$3,0907%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 109 | $39,901 |
| Otsuka America Pharmaceutical, Inc. | 10 | $481 |
| Alkermes, Inc. | 7 | $321 |
| Neos Therapeutics, LP | 5 | $219 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $149 |
| Lundbeck LLC | 10 | $138 |
| Eisai Inc. | 10 | $131 |
| E.r. Squibb & Sons, L.L.C. | 1 | $108 |
| Myriad Genetic Laboratories, Inc. | 1 | $97 |
| Sunovion Pharmaceuticals Inc. | 5 | $75 |
| Vanda Pharmaceuticals Inc. | 2 | $61 |
| Adlon Therapeutics L.p. | 3 | $43 |
| Aytu Biopharma, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Biogen | 1 | $16 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$38,729
- ARISTADA$468
- REXULTI$125
- Cotempla XR-ODT$119
- Adzenys XR-ODT$119
- ZolpiMist$119
- ARISTADA INITIO$117
- COBENFY$108
- CAPLYTA$100
How this compares
$42,051 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Pensacola
- Scott DurrancePensacola$224K
- Leif SternungPensacola$15K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.